Immunetics Featured at Boston Startup America Event

BOSTON, MASSACHUSETTS, March 30, 2011 – Immunetics, Inc., a provider of innovative clinical diagnostic tests, was highlighted yesterday as part of a roundtable and tour for President Barack Obama’s Startup America initiative. Hosted by Boston Mayor Thomas Menino, senior administration officials from the U.S. Food and Drug Administration, Small Business Administration, State Department, and Department of Energy visited the company’s facilities to gain insight into Immunetics’ success. The event was part of Startup America’s effort to accelerate high-growth entrepreneurship across the country.

"Immunetics came to the South Boston Innovation District after recognizing that an attractive business location with talented people, reasonable facility costs, and access to capital would be a great place to achieve their next stage of growth," Mayor Menino said. "Now, the city's partnership with Immunetics has generated benefits that exceeded all of our expectations. Together, we've created jobs, won millions of dollars in grants and contracts, and most importantly, achieved medical advances that will help millions of people overcome life-threatening diseases."

Immunetics President and Chief Executive Officer Dr. Andrew Levin said LifeTech Boston, the Mayor’s program that supports the life sciences industry in the city and is administered through the Boston Redevelopment Authority, helped locate a facility that could support the company’s growth objectives, plus secure a loan to finance its build-out.

“Since then, we have almost tripled the size of our workforce, won over $22 million in grants and contracts, and developed better diagnostics for diseases such as HIV, Lyme disease, and other serious infections that threaten our blood supply,” said Dr. Levin. “Our move to the Innovation District has been the key to Immunetics’ growth and success over the past 7 years.”

The Startup America initiative’s goal is to increase opportunities for entrepreneurs by expanding access to capital, developing education and mentorship programs, and improving collaboration between startup and established companies.

* * * * * * *

Immunetics ( offers state-of-the-art assay technology for infectious disease diagnosis and pathogen detection. For over 10 years, the company has been a leading innovator of tests for bacterial, viral, and parasitic diseases. Immunetics produces and markets a range of infectious disease assay kits and instruments.  Its mission is better, cost-efficient care through more accurate diagnosis.